Jim Beitel
Corporate Officer/Principal bij FATE THERAPEUTICS, INC.
Profiel
Jim Beitel is currently the Senior Vice President-Corporate Development at Fate Therapeutics, Inc. He previously worked as the Director & Director-Business Development at Zacharon Pharmaceuticals, Inc. and as the Vice President-Corporate Development & Operations at Avanir Pharmaceuticals, Inc. Mr. Beitel received his undergraduate degree from the University of Kansas and his MBA from Harvard Business School.
Actieve functies van Jim Beitel
Bedrijven | Functie | Begin |
---|---|---|
FATE THERAPEUTICS, INC. | Corporate Officer/Principal | 14-09-2017 |
Eerdere bekende functies van Jim Beitel
Bedrijven | Functie | Einde |
---|---|---|
Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Director/Board Member | 01-08-2011 |
AVANIR PHARMACEUTICALS INC | Chief Operating Officer | 01-08-2007 |
Opleiding van Jim Beitel
University of Kansas | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Zacharon Pharmaceuticals, Inc.
Zacharon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Zacharon Pharmaceuticals, Inc. developed small molecular drugs. The company was founded by Jeffrey D. Esko, Charles A. Glass and Brett E. Crawford in 2004 and was headquartered in Novato, CA. | Health Technology |